218
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

In vitro characterization studies of self-microemulsified bosentan systems

, , , &
Pages 989-995 | Received 29 Sep 2016, Accepted 13 Jan 2017, Published online: 16 Feb 2017

References

  • Sailesh M, Norm C, Arun C. Time to effectively address hypertension in India. Indian J Med Res 2013;137:627–31.
  • MacGregor AJ, Canavan R, Knight C. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001;40:453–9.
  • Hoendermis ES. Pulmonary arterial hypertension: an update. Neth Heart J 2011;19:514–22.
  • Simonneau G. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43–S54.
  • Chopra S, Badyal DK, Baby PC, Cherian D. Pulmonary arterial hypertension: advances in pathophysiology and management. Indian J Pharmacol 2012;44:4–11.
  • Newman JH, Wheller L, Lane KB. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 2001;345:319–24.
  • Natarajan R. Recent trends in pulmonary arterial hypertension. Lung India 2011;28:39–48.
  • Gabbay E, Fraser J, McNeil K. Review of bosentan in the management of pulmonary arterial hypertension. Vasc Health Risk Manag 2007;3:887–900.
  • Galiè N, Rubin L, Hoeper M. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY Study). Lancet 2008;371:2093–100.
  • Xu S-W, Denton CP, Holmes A, et al. Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts. J Cardiovasc Pharmacol 1998;31:S360–S3.
  • Davie N, Haleen SL, Upton PD, et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002;165:398–405.
  • Mansoor AM, Honda M, Saida K. Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem Biophys Res Commun 1995;215:981–6.
  • Muller DN, Mervaala EM, Schmidt F. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension 2000;36:282–90.
  • Filippos K, Wu Y. Understanding the effect of API properties on bioavailability through absorption modeling. AAPS J 2008;10:516–25.
  • Suresh S, Shivakumar HN, Kumar GK. Effect of β cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets. Indian J Pharm Sci 2006;68:301–7.
  • Chaumeil JC. Micronisation, a method of improving the bioavailability of poorly soluble drugs, methods and findings in experimental and clinical pharmacology. Eur J Pharm Sci 2000;10:17–28.
  • Vadlamudi HC, Raju YP, Asuntha G, et al. Assessment of hupu gum for its carrier property in the design and evaluation of solid mixtures of poorly water soluble drug – rofecoxib. Curr Drug Deliv 2014;11:62–71.
  • Hecq J, Deleers M, Fanara D, et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005;299:167–77.
  • Katja E, Alenka Z, Mirjana G, Franc V. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm 2013;63:427–45.
  • Sandeep K, Mohanvarma M, Veerabhadhraswamy P. Oral lipid-based drug delivery systems – an overview. Acta Pharm Sin B 2013;3:361–72.
  • Nazzal Guven N, Reddy IK, Khan MA. Preparation and characterization of coenzyme Q10-Eudragit solid dispersion. Drug Dev Ind Pharm 2002;28:49–57.
  • Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60:625–37.
  • Pramod K, Peeyush K, Rajeev K, et al. An overview of lipid based formulation for oral drug delivery. Drug Inv Today 2010;2:390–5.
  • Driscoll CMO. Lipid based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002;15:405–15.
  • Harini Chowdary V, Prasanna Raju Y, Basaveswara Rao MV, et al. Potential of microemulsified entacapone drug delivery systems in the management of acute Parkinson's disease. J Acute Dis 2016;5:315–25.
  • Nanda Kishore R, Prasanna Raju Y, Harini Chowdary V, et al. Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design. Drug Dev Ind Pharm 2015;41:1213–22.
  • Zhang J, Lv Y, Wang B, et al. Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions. Mol Pharm 2015;12:695–705.
  • Gershanik T, Benzeno S, Benita S. Interaction of a selfemulsifying lipid drug delivery system with the inverted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res 1998;15:863–9.
  • Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech 2010;11:9–17.
  • Singh D, Pathak K. Hydrogen bond replacement – unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use. Int J Pharm 2013;441:99–110.
  • Salonen J, Laitinen L, Kaukonen A, et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Control Release 2005;108:362–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.